← Back to Search

Fermented Soy Product

Q CAN PLUS for Immune Response (IS Trial)

N/A
Waitlist Available
Led By Joan Sabate, DrPH
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 16 to week 20
Awards & highlights

IS Trial Summary

This trial will test whether Q CAN PLUS powder can improve immune, inflammatory, and cognitive function.

Eligible Conditions
  • Immune Response
  • Inflammation
  • Cognitive Impairment

IS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 16 to week 20
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 16 to week 20 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in complete blood count (CBC) and differential count
Changes in immune status measurements
Changes in inflammatory factors and cytokines
+5 more
Secondary outcome measures
Changes from baseline in global cognitive composite score
Changes in the upper respiratory infection questionnaire score

IS Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Q CAN PLUS POWDERExperimental Treatment1 Intervention
QCAN PLUS POWDER: 2 pouches per day, each pouch contains (12-15 gms of fermented soy powder)
Group II: PlaceboPlacebo Group1 Intervention
Sprouted brown rice protein with flavor (provided by BESO Biological Research Inc.)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Q CAN PLUS
2018
N/A
~90

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,926 Total Patients Enrolled
Joan Sabate, DrPHPrincipal InvestigatorLoma Linda University
4 Previous Clinical Trials
55,969 Total Patients Enrolled

Media Library

Q CAN PLUS (Fermented Soy Product) Clinical Trial Eligibility Overview. Trial Name: NCT04866576 — N/A
Immune Response Research Study Groups: Q CAN PLUS POWDER, Placebo
Immune Response Clinical Trial 2023: Q CAN PLUS Highlights & Side Effects. Trial Name: NCT04866576 — N/A
Q CAN PLUS (Fermented Soy Product) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04866576 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Might I be a fit for this clinical trial?

"This study, which needs approximately 62 participants, is for those aged 65 to 80 who suffer from inflammation."

Answered by AI

Does this research allow for participants who are not yet adults?

"Individuals that meet the age requirements of this study (between 65-80 years old)"

Answered by AI

Are there any openings for this clinical research project?

"This trial, which began recruitment on 8/12/2021, is still looking for participants, as indicated by clinicaltrials.gov."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Effect of a Fermented Soy Product on Cognition, Immune Status and Vaccine
Joan Sabate,DrPH, MD 2021. "Effect of a Fermented Soy Product on Cognition, Immune Status and Vaccine". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04866576.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top